BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 251 filers reported holding BLUEBIRD BIO INC in Q1 2020. The put-call ratio across all filers is 1.33 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,752,940 | +4709.5% | 836,760 | +4548.7% | 0.01% | +900.0% |
| Q1 2023 | $57,240 | -85.7% | 18,000 | -71.6% | 0.00% | -87.5% |
| Q3 2022 | $401,000 | -36.2% | 63,296 | -51.2% | 0.01% | -52.9% |
| Q1 2022 | $629,000 | +522.8% | 129,729 | +1185.6% | 0.02% | +466.7% |
| Q4 2021 | $101,000 | -86.2% | 10,091 | -73.6% | 0.00% | -85.7% |
| Q3 2021 | $731,000 | +168.8% | 38,247 | +350.4% | 0.02% | +133.3% |
| Q2 2021 | $272,000 | -40.4% | 8,492 | +63.3% | 0.01% | -69.0% |
| Q4 2019 | $456,000 | -84.9% | 5,200 | -84.2% | 0.03% | -83.9% |
| Q3 2019 | $3,019,000 | +208.4% | 32,867 | +326.8% | 0.18% | +68.2% |
| Q2 2019 | $979,000 | -49.8% | 7,700 | -37.9% | 0.11% | -66.7% |
| Q1 2019 | $1,951,000 | – | 12,400 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Monashee Investment Management LLC | 125,000 | $13,131,000 | 5.55% |
| Cormorant Asset Management, LP | 275,000 | $28,889,000 | 4.79% |
| Eventide Asset Management | 569,700 | $59,847,000 | 3.73% |
| Crosspoint Capital Strategies, LLC | 28,937 | $3,040,000 | 2.66% |
| Casdin Capital, LLC | 65,000 | $6,828,000 | 2.53% |
| ARK Investment Management | 119,683 | $12,573,000 | 2.45% |
| RTW INVESTMENTS, LP | 104,383 | $10,965,000 | 2.31% |
| Taylor Wealth Management Partners | 38,368 | $4,031,000 | 1.82% |
| First Light Asset Management, LLC | 33,780 | $3,549,000 | 1.19% |
| Atika Capital Management LLC | 25,000 | $2,627,000 | 0.92% |